[Form 4] UNITED STATES ANTIMONY CORP Insider Trading Activity

Rhea-AI Filing Summary

Jeffrey R. Fink, an officer and director of United States Antimony Corp (UAMY), reported the sale of 12,500 shares of the company's common stock on September 24, 2025 at a reported price of $7.87 per share. After the transaction he beneficially owned 66,833 shares. The Form 4 was signed on October 2, 2025. The filing discloses a straightforward open-market disposition by an insider and contains no derivative transactions or additional explanations.

Positive

• None.

Negative

• Insider disposition: Reporting person sold 12,500 shares, which may be viewed as a negative signal to some investors even though no reason is provided.

Insights

Securities Analyst

TL;DR: Insider sold 12,500 shares at $7.87, leaving 66,833 shares beneficially owned; filing is routine disclosure.

The Form 4 shows a single non-derivative disposition by Jeffrey R. Fink, an officer and director, executed on 09/24/2025. The sale price is explicitly stated as $7.87 and the post-transaction beneficial ownership is 66,833 shares. There are no derivative instruments reported and no additional context or explanations provided in the filing. From a reporting perspective this is a standard Section 16 disclosure of an insider sale.

Corporate Governance Expert

TL;DR: The disclosure is complete for the reported sale but provides no rationale; it is a routine compliance filing.

The document identifies the reporting person, relationship to the issuer, transaction date, amount sold, and the price per share. It meets the Form 4 requirements by reporting the insider disposition and the resulting beneficial ownership. The filing does not include any amendments, derivative activity, or explanatory notes, so governance implications are limited to the fact of an insider sale without stated reason.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Fink Jeffrey Russell

(Last) (First) (Middle)

4438 W LOVERS LANE

UNIT 100

(Street)

DALLAS TX 75209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, General Manager BRZ

3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/24/2025		D		12,500	D	$7.87	66,833	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Fink J.	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UAMY report in this Form 4?

The Form 4 reports that Jeffrey R. Fink sold 12,500 shares of United States Antimony Corp on 09/24/2025 at $7.87 per share.

How many UAMY shares does the reporting person own after the sale?

After the reported transaction, the filing shows beneficial ownership of 66,833 shares.

What is Jeffrey R. Fink's relationship to UAMY?

Jeffrey R. Fink is reported as an Officer (VP, General Manager BRZ) and a Director of United States Antimony Corp.

Does the Form 4 report any derivative securities or other transactions?

No. The filing contains only a non-derivative disposition of common stock and does not report any derivative securities.

When was the Form 4 signed?

The signature date on the Form 4 is 10/02/2025.